Fat tissue analysis in the management of patients with systemic amyloidosis

Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations

Volumn , Issue , 2012, Pages 191-207

  Bijzet, Johan ^a   van Gameren, Ingrid I ^a   Hazenberg, Bouke P C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

16 Gauge needle; Abdominal subcutaneous fat tissue; Accuracy; Age; Amino acid sequence; Amyloid A (AA) amyloid; Amyloid detection; Amyloid progression; Amyloid protein precursors; Amyloid quantification; Amyloid regression; Amyloid typing; Amyloidogenesis; Apolipoprotein AI (AApoAI) amyloid; Apolipoprotein AII (AApoAII) amyloid; Apolipoprotein E; Birefringence; Chemical tissue analysis; Collagen IV; Composition of amyloid; Computer assisted image analysis; Confidence interval; Congo red stain; Current practice of fat tissue aspiration; Cutoff values; Deposition of amyloid in vivo; Disease severity; Entactin; Enzyme linked immunosorbent assay; False negative; False positive; Familial Mediterranean fever; Fat tissue aspiration; Fibrinogen a chain (AFib) amyloid; Fine needle biopsy; Follow up; Gelsolin (AGel) amyloid; Glycosaminoglycans; Immunochemical analysis; Immunodiffusion; Immunoelectron microscopy; Immunofluorescence; Immunoglobulin heavy chain (AH) amyloid; Immunoglobulin light chain (AL) amyloid; Immunohistochemistry; Insulin (AIns) amyloid; Laminin; Laser microdissection; Light chain kappa; Light chain lambda; Lysozyme (ALys) amyloid; Mass spectrometry; Matrix assisted laser desorption ionization; Men; Micropurification techniques; Mutated TTR; Negative predictive value; Nephelometry; Number of major organs; Peptide mass fingerprinting; Positive predictive value; Proteomic techniques; Reference range; Removal of amyloid in vivo; Rheumatoid arthritis; Scoring system; Semiquantitative grading; Sensitivity; Serum amyloid A protein; Serum amyloid P component; Specificity; Surgical biopsy; Survival; Transthyretin; Transthyretin (ATTR) amyloid; Treatment; Trucut biopsy; Two dimensional polyacrylamide gel electrophoresis; Western blot analysis; Wild type TTR; Women; 2 Microglobulin (A 2 M) amyloid; ratio

Indexed keywords

EID: 84876743231     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60761-389-3_15     Document Type: Chapter

References (74)

1. Schilder P. über die amyloide Entartung der Haut. Frankfurt Z Pathol. 1909;3:782-94.
2. Westermark P, Stenkvist B. Diagnosis of secondary generalized amyloidosis by fine needle biopsy of the skin. Acta Med Scand. 1971;190:453-4.
3. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522-3.
4. Westermark P, Stenkvist B, Natvig JB, et al. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis. 1979;38:68-71.
5. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med. 1983;143:1549-52.
6. Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol. 1989;7:407-10.
7. Westermark P. Diagnosis and characterization of systemic amyloidosis by biopsy of subcutaneous abdominal fat tissue. Intern Med Spec. 1984;5:154-60.
8. Olsen KE, Sletten K, Westermark P. The use of subcutaneous fat tissue for amyloid typing by enzymelinked immunosorbent assay. Am J Clin Pathol. 1999;111:355-62.
9. Hazenberg BP, Limburg PC, Bijzet J, van Rijswijk MH. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis. Ann Rheum Dis. 1999;58:96-102.
10. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10:355-63.
11. Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134:545-51.
12. Ponce P, Carvalho F, Coelho A. Valeur de la ponctionaspiration de la graisse sous-cutanée dans le diagnostic de l'amylose. Nephrologie. 1986;7:25-7.
13. Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol. 1987;16:429-31.
14. Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929-33.
15. Sorsa S, Happonen RP, Klemi P. Oral biopsy and fine needle aspiration biopsy from subcutaneous fat in diagnosis of secondary amyloidosis. Int J Oral Maxillofac Surg. 1988;17:14-6.
16. Duston MA, Skinner M, Meenan RF, Cohen AS. Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum. 1989;32:82-5.
17. Dupond JL, de Wazières B, Saile R, Closs F, Viennet G, Kantelip E, Fest T, Vuitton DA. L'amylose systémique du sujet âgé: valeur diagnostique de l'examen de la graisse sous-cutanée abdominale et des glandes salivaires accessoires. étude prospective chez 100 patients âgés. Rev Med Interne. 1995;16:314-7.
18. Masouye I. Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: an analysis of 100 cases. Am J Dermatopathol. 1997;19:41-5.
19. Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. Diagn Cytopathol. 2001;24:181-5.
20. Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol. 2004;30:178-81.
21. van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015-21.
22. Dhingra S, Krishnani N, Kumari N, Pandey R. Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis. Acta Cytol. 2007;51:860-4.
23. Blumenfeld W, Hildebrandt RH. Fine needle aspiration of abdominal fat for the diagnosis of amyloidosis. Acta Cytol. 1993;37:170-4.
24. Lipschutz JH, Miller T, Yen TS, Vartanian RK, Graber ML, Damon L. Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol. 1995;15:431-5.
25. Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid. 2010;17:101-4.
26. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid. 2002;9:108-14.
27. Hazenberg AJ, Dikkers FG, Hawkins PN, et al. Laryngeal presentation of systemic AApoAI amyloidosis in patients with apolipoprotein AI variants Leu174Ser and Leu178Pro. Laryngoscope. 2009;119:608-15.
28. Varga J, Idelson BA, Felson D, Skinner M, Cohen AS. Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med. 1987;147:1455-7.
29. Orfila C, Goffinet F, Goudable C, et al. Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients. Am J Nephrol. 1988;8:454-6.
30. Solé Arqués M, Campistol JM, Muñoz-Gómez J. Abdominal fat aspiration biopsy in dialysis-related amyloidosis. Arch Intern Med. 1988;148:988.
31. Sethi D, Cary NR, Brown EA, Woodrow DF, Gower PE. Dialysis-associated amyloid: systemic or local? Nephrol Dial Transplant. 1989;4:1054-9.
32. Uemichi T, Liepnieks JJ, Gertz MA, Benson MD. Fibrinogen A alpha chain Leu 554: an African- American kindred with late onset renal amyloidosis. Amyloid. 1998;5:188-92.
33. Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108:209-13.
34. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5:55-66.
35. Vrana JA, Theis JD, Gamez JD, et al. Diagnosis and classification of systemic amyloidosis in abdominal subcutaneous fat aspiration specimens using mass spectrometry-based proteomics. XIIth International Symposium on Amyloidosis, Rome. Abstract OP-033. Amyloid. 2010;17(S1):55-56 36. Sie MP, van der Wiel HE, Smedts FM, de Boer AC. Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med. 2010;68:138-40.
36. Sie MP, van der Wiel HE, Smedts FM, de Boer AC. Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med. 2010;68:138-40
37. Shikama Y, Kitazawa J, Yagihashi N, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med. 2010;49:397-401.
38. Orfila C, Giraud P, Modesto A, Suc JM. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol. 1986;17:366-9.
39. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216:253-61.
40. Kaplan B, Vidal R, Kumar A, Ghiso J, Gallo G. Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat. Am J Clin Pathol. 1999;112:403-7.
41. Hazenberg BP, Bijzet J, Limburg PC, et al. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid. 2007;14:133-40.
42. Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol. 1988;6:395-7.
43. El Mansoury TM, Hazenberg BP, El Badawy SA, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42-7.
44. Sjöholm K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab. 2005;90:2233-9.
45. Picken MM, Herrera GA. The burden of "sticky" amyloid: typing challenges. Arch Pathol Lab Med. 2007;131:850-1.
46. Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16:196-203.
47. Pras M, Schubert M, Zucker-Franklin D, et al. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968;47:924-33.
48. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885-90.
49. Westermark P, Benson L, Juul J, Sletten K. Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis. J Clin Pathol. 1989;42: 817-9.
50. Forsberg AH, Sletten K, Benson L, et al. Abdominal fat biopsy for characterization of the major amyloid fibril proteins by amino acid sequence. In: Natvig JB, Forre O, Husby G, et al., editors. Amyloid and amyloidosis 1990. Dordrecht/Norwell, MA: Kluwer; 1990. p. 797-800.
51. Kaplan B, Hrncic R, Murphy CL, Gallo G, Weiss DT, Solomon A. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol. 1999;309:67-81.
52. Kaplan B, Murphy CL, Ratner V, Pras M, Weiss DT, Solomon A. Micro-method to isolate and purify amyloid proteins for chemical characterization. Amyloid. 2001;8:22-9.
53. Kaplan B, Shtrasburg S, Pras M. Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol. 2003;56:86-90.
54. Murphy CL, Eulitz M, Hrncic R, et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol. 2001;116:135-42.
55. Kaplan B, Martin BM, Livneh A, Pras M, Gallo GR. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol. 2004;121:794-800.
56. Murphy CL, Wang S, Williams T, Weiss DT, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412: 48-62.
57. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen 3rd HR, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957-9.
58. Lavatelli F, Perlman DH, Spencer B, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 2008;7:1570-83.
59. Gómez-Casanovas E, Sanmartí R, Solé M, Cañete JD, Muñoz-Gómez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic longterm followup study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66-72.
60. Bardarov S, Michael CW, Pu RT, Pang Y. Computerassisted image analysis of amyloid deposits in abdominal fat pad aspiration biopsies. Diagn Cytopathol. 2009;37:30-5.
61. van Gameren II, Hazenberg BP, Bijzet J, et al. Amyloid load in fat tissue in patients with amyloidosis reflects disease severity and predicts survival. Arthritis Care Res (Hoboken). 2010;62:296-301.
62. Haagsma EB, van Gameren II, Bijzet J, Posthumus MD, Hazenberg BP. Familial amyloidotic polyneuropathy: long-term follow-up of abdominal fat tissue aspirate in patients with and without liver transplantation. Amyloid. 2007;14:221-6.
63. Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl. 2008;14:563-70.
64. Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol. 2011;42: 236-43.
65. Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med. 2011;89:171-80.
66. van Gameren II, van Rijswijk MH, Bijzet J, Vellenga E, Hazenberg BP. Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica. 2009;94:1094-100.
67. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 2005;48:519-28.
68. Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol Histopathol. 2005;20:1295-307.
69. Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol. 1999;155:123-33.
70. Elimova E, Kisilevsky R, Szarek WA, Ancsin JB. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J. 2004;18:1749-51.
71. Magy N, Benson MD, Liepnieks JJ, Kluve-Beckerman B. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid. 2007;14:51-63.
72. Fat aspiration procedure for the detection of amyloid-instruction video. http://www.amyloid.nl/ investigations.htm. Accessed 16 May 2011.
73. Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. J Nucl Med. 1998;39: 699-706.
74. Commercial kit for SAA ELISA. http://www.hycultbiotech.com/acute-phase-proteins/-p11209.html. Accessed 20 May 2011.